Home > > > Report Detail

U.S. Insomnia Market by Non-Pharmacological Therapy (CBTI, Hypnotherapy), Prescription Sleep Aids (Benzodiazepines, Non-Benzodiazepines (Zaleplon), Orexin Antagonist) & OTC Treatment (Antihistamine, Melatonin, Valerian Root)) - Forecasts to 2021

Publisher Name :
Date: 25-Jan-2017
No. of pages: 144
Inquire Before Buying

The U.S. insomnia market is projected to reach USD 4.24 billion by 2021 from USD 3.38 billion in 2016, growing at a CAGR of 4.6% from 2016 to 2021.

In 2016, the cognitive behavioral therapy for insomnia (CBTI) segment is expected to account for the largest share of the market. The other alternative therapies include exercise/yoga, acupuncture, biofeedback, bright light therapy, music therapy, and aroma therapy.

In 2016, the prescription sleep aids segment is expected to account for the largest share of the U.S. insomnia pharmacological treatment market. The launch of Belsomra(Merck & Co., Inc) in 2014 in the U.S. and the anticipated launch of E-2006 (Eisai Co., Ltd.) is expected to drive the growth of the market during the forecast years. However, due to the erosion in branded drugs sales and growing adoption of generics attributed to their low cost and equal efficacy as compared to branded products may hinder the growth of the market. In 2016, the zolpidem segment is expected to account for the largest share of the non-benzodaizepines prescription sleep aids market. However, higher adoption of generic products that are available are cheaper price is negatively affecting the growth of the market.

The over-the-counter sleep aids segment of the U.S. insomnia pharmacological treatment market is expected to grow at the highest CAGR during the forecast period. Reasons attributing to the growth of this market include easier availability, low prices, and publicity regarding the side effects of the prescription sleep aids has also steered the patients towards OTC sleep aid. In 2016, the antihistamines sleep aids segment is expected to hold the largest share of the over-the-counter sleep aids market, whereas, melatonin is expected to grow at the highest CAGR during the forecast period. Growing awareness about the advantages of melatonin such as least amount of side effects, reduces stress levels, and its growing consumption is driving the growth of this segment in the U.S.

Some of the key players offering insomnia treatment (pharmacological)include Eisai, Co. Ltd. (Japan), Merck & Co., Inc. (U.S.), Meda Consumer Healthcare Inc. (U.S.), Pfizer, Inc. (U.S.), Sanofi (France), Takeda Pharmaceutical Company Ltd. (Japan), Pernix Therapeutics (U.S.), and Purdue Pharma L.P. (U.S.).

Research Coverage

The market study covers the U.S. insomnia market, by type of treatment, to estimate the overall market size during 2013 to 2021.This report also covers the drivers, restraints, and opportunities of the market along with the competitive landscape of the U.S. insomnia market players.

Reasons to buy this report:

The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn helps firms to garner a greater market share. Firms purchasing the report could use any one or a combination of the below-mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market shares.

The report provides insights on the following pointers:


  • Market Penetration: Comprehensive information regarding products and services offered by the top players in the U.S. insomnia market

  • Product Development/Innovation: Detailed insights on research & development activities, and new product launches in the U.S. insomnia market

  • Market Diversification: Exhaustive information about new products, recent developments, and investments in the U.S. insomnia market

  • Competitive Assessment: In-depth assessment of strategies, products, and pipeline products of the key players in the U.S. insomnia market

U.S. Insomnia Market by Non-Pharmacological Therapy (CBTI, Hypnotherapy), Prescription Sleep Aids (Benzodiazepines, Non-Benzodiazepines (Zaleplon), Orexin Antagonist) & OTC Treatment (Antihistamine, Melatonin, Valerian Root)) - Forecasts to 2021

Table of Contents

1 Introduction
1.1 Objectives of the Study
1.2 Market Definition
1.2.1 Markets Covered
1.2.2 Years Considered for the Study
1.3 Currency
1.4 Limitations
1.5 Key Stakeholders/Influencers

2 Research Methodology
2.1 Market Size Estimation – Non-Pharmacological Treatments Market
2.1.1 Market Breakdown and Data Triangulation
2.1.2 Key Data From Secondary Sources
2.1.3 Key Data From Primary Sources
2.2 Market Size Estimation – Pharmacological Treatments Market
2.2.1 Market Forecast Model
2.2.2 Market Size Estimation
2.2.3 Market Breakdown and Data Triangulation
2.2.4 Key Data From Primary and Secondary Sources
2.3 Research Assumptions

3 Executive Summary

4 Premium Insights
4.1 Physicians Views About Cognitive Behavioral Therapy for Insomnia (CBTI)
4.2 Age-Wise Commonly Used/Prescribed Treatments for Each Type of Insomnia
4.3 List of Ongoing Phase-III Clinical Trails for Insomnia
4.4 U.S. Insomnia Market: Consumer Selection Criteria

5 Market Overview
5.1 Introduction
5.2 Market Dynamics
5.2.1 Market Drivers
5.2.1.1 Government Support to Control Rising Insomnia Cost
5.2.1.2 OTC Sleep Aids to Drive the Pharmacological Treatment Market Growth
5.2.2 Market Restraints
5.2.2.1 Erosion in Branded Prescription Sleep Aid Sales Due to Growing Adoption of Generics
5.2.2.2 Side Effects of Benzodiazepine and Non-Benzodiazepine Drugs
5.2.2.3 Non Pharmacological Therapies to Restrict the Growth of Drugs Market
5.2.3 Market Opportunities
5.2.3.1 Unmet Need for More Effective and Safe Drugs
5.2.3.2 Presence of Large Insomnia Population Pool

6 Non-Pharmacological Treatment Market
6.1 Introduction
6.1.1 Cognitive Behavioral Therapy for Insomnia (CBTI)
6.1.2 Hypnotherapy
6.1.3 Other Alternative Therapies
6.2 Therapy Recommendation, 2015 (%)
6.3 Qualitative Assessment

7 Pharmacological Treatment Market
7.1 Introduction
7.2 U.S.: Insomnia Pharmacological Treatment Market Size, By Type
7.2.1 U.S.: Prescription Sleep Aids Market Size for Insomnia
7.2.1.1 U.S.: Prescription Sleep Aids Market Size for Insomnia, By Type
7.2.1.1.1 U.S.: Non- Benzodiazepine Sleep Aids Market Size for Insomnia, By Type
7.2.2 U.S.: Over-The-Counter (OTC) Sleep Aids Market Size for Insomnia, By Type

8 Competitive Landscape
8.1 Key Players in the U.S. Insomnia Pharmacological Treatment Market
8.2 Top Available Mobile Applications for Insomnia
8.3 Corporate Strategies Followed Within U.S. Insomnia Market
8.4 Competitive Situations & Trends
8.4.1 Product Launches & Approvals
8.4.2 Collaborations, Agreements and Partnerships
8.4.3 Acquisitions

9 Company Profiles
9.1 Introduction
9.2 Merck & Co., Inc.
9.3 Eisai Co., Ltd.
9.4 Meda Consumer Healthcare, Inc
9.5 Takeda Pharmaceuticals Company Ltd.
9.6 Pfizer Inc.
9.7 Sanofi
9.8 Vanda Pharmaceuticals
9.9 Pernix Therapeutics
9.10 Purdue Pharmaceuticals L.P.

10 Appendix
10.1 Discussion Guide
10.2 Related Reports
10.3 Related Reports
10.4 Knowledgestore Subscription Portal
10.5 MnM Knowledgestore: Snapshot
10.6 RT: Real-Time Market Intelligence
10.7 Disclaimer
10.8 Author Details

List of Tables

Table 1 Key Stakeholders/Influencers for Diagnosed Insomnia Patients
Table 2 Physicians Views About Cognitive Behavioral Therapy for Insomnia (CBTI)
Table 3 Age-Wise Commonly Used/Prescribed Treatments for Each Type of Insomnia
Table 4 List of Ongoing Phase-III Clinical Trails for Insomnia
Table 5 Insomnia Treatment Selection Criteria: Impact Analysis
Table 6 U.S. Insomnia Market, By Non-Pharmacological Treatment (Qualitative Assessment)
Table 7 U.S.: Insomnia Pharmacological Treatment Market Size , By Type, 2013-2021 (USD Million)
Table 8 U.S.: Insomnia Pharmacological Treatment Market Size , By Prescription Sleep Aids, 2013-2021 (USD Million)
Table 9 U.S.: Prescriptions Sleep Aids Market Size for Insomnia, By Type, 2013-2021 (USD Million)
Table 10 U.S.: Non- Benzodiazepine Sleep Aids Market Size for Insomnia, By Type, 2013-2021 (USD Million)
Table 11 U.S.: Over-The-Counter (OTC) Sleep Aids Market Size for Insomnia, By Type, 2013-2021 (USD Million)
Table 12 Key Players in the U.S. Insomnia Pharmacological Treatment Market (2016)
Table 13 Top Available Mobile Applications for Insomnia (2016)
Table 14 Product Launches and Approvals, 2013 –2016
Table 15 Collaborations, Agreements and Partnerships 2013–2016
Table 16 Acquisitions, 2013–2016

List of Figures

Figure 1 Segmentation & Coverage
Figure 2 Prevalence of Insomnia, By Type (2012-2015)
Figure 3 Research Design – Non-Pharmacological Treatments Market
Figure 4 Market Breakdown and Data Triangulation – Non-Pharmacological Treatments Market
Figure 5 Forecasting Model– Pharmacological Treatments Market
Figure 6 Market Size Estimation – Pharmacological Treatments Market
Figure 7 Market Breakdown and Data Triangulation – Pharmacological Treatments Market
Figure 8 Assumptions for the Study
Figure 9 U.S. Insomnia Market Scope
Figure 10 Pharmacological Treatment Market Share, By Type (2014-2021)
Figure 11 U.S. Insomnia Market: Consumer Selection Criteria
Figure 12 U.S. Insomnia Market: Drivers, Restraints, and Opportunities
Figure 13 U.S. Insomnia Market, By Non-Pharmacological Treatment, Therapy Recommendation, 2015 (%)
Figure 14 U.S. Insomnia Pharmacological Treatment Market Segmentation
Figure 15 U.S.: Insomnia Pharmacological Treatment Market, 2013-2021 (USD Million)
Figure 16 Market Share: Pharmacological Treatment Market (2016)
Figure 17 Market Share: Prescription Sleep Aids Market (2016)
Figure 18 U.S. Insomnia Prescription Sleep Aids Market Snapshot
Figure 19 Market Share: Non-Benzodiazepine Sleep Aids Market (2016)
Figure 20 Market Share: Non-Benzodiazepine Sleep Aids Market (2016)
Figure 21 U.S.: Over-The-Counter (OTC) Sleep Aids Market Snapshot
Figure 22 Battle for Market Share: Product Launches and Approvals—Key Strategies Adopted By Market Players (2013-2016)
Figure 23 Geographic Revenue Mix of Major Players in the U.S. Insomnia Market (2016)
Figure 24 Sumitomo Dainippon Pharma Co., Ltd.: Company Snapshot (2015)
Figure 25 Sanofi: Company Snapshot (2015)
Figure 26 Pfizer Inc: Company Snapshot (2015)
Figure 27 Takeda Pharmaceutical Company Ltd.: Company Snapshot (2015)
Figure 28 Merck & Co., Inc.: Company Snapshot (2015)
Figure 29 Meda Consumer Healthcare Inc.: Company Snapshot (2015)
Figure 30 Eisai Co., Ltd.: Company Snapshot (2015)
Figure 31 Purdue Pharmaceuticals L.P.: Company Snapshot (2015)
Figure 32 Pernix Therapeutics: Company Snapshot (2015)
Figure 33 Vanda Pharmaceuticals: Company Snapshot (2015)

  • Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029
    Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118
    The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......
  • Global Non-imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95
    The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90
    The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......
  • Global PCR Equipment Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77
    The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......
  • Global Disposable Sterile Syringes and Needles Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109
    The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......
  • Global Orthopaedic Power Tools Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......
  • Global Cerebrospinal Fluid Management Devices Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......
  • Global CAD & CAM Milling Burs Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79
    The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......
  • Global Artificial Teeth Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98
    The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs